251 related articles for article (PubMed ID: 15792796)
1. Isolation and structural characterization of epilancin 15X, a novel lantibiotic from a clinical strain of Staphylococcus epidermidis.
Ekkelenkamp MB; Hanssen M; Danny Hsu ST; de Jong A; Milatovic D; Verhoef J; van Nuland NA
FEBS Lett; 2005 Mar; 579(9):1917-22. PubMed ID: 15792796
[TBL] [Abstract][Full Text] [Related]
2. Elucidation of the primary structure of the lantibiotic epilancin K7 from Staphylococcus epidermidis K7. Cloning and characterisation of the epilancin-K7-encoding gene and NMR analysis of mature epilancin K7.
van de Kamp M; van den Hooven HW; Konings RN; Bierbaum G; Sahl HG; Kuipers OP; Siezen RJ; de Vos WM; Hilbers CW; van de Ven FJ
Eur J Biochem; 1995 Jun; 230(2):587-600. PubMed ID: 7607233
[TBL] [Abstract][Full Text] [Related]
3. Sequence analysis by NMR spectroscopy of the peptide lantibiotic epilancin K7 from Staphylococcus epidermidis K7.
van de Kamp M; Horstink LM; van den Hooven HW; Konings RN; Hilbers CW; Frey A; Sahl HG; Metzger JW; van de Ven FJ
Eur J Biochem; 1995 Feb; 227(3):757-71. PubMed ID: 7867636
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of a bioactive lantibiotic produced by Staphylococcus warneri.
Petersen J; Boysen A; Fogh L; Tabermann K; Kofoed T; King A; Schrotz-King P; Hansen MC
Biol Chem; 2009; 390(5-6):437-44. PubMed ID: 19361283
[TBL] [Abstract][Full Text] [Related]
5. Chemical synthesis and biological activity of analogues of the lantibiotic epilancin 15X.
Knerr PJ; van der Donk WA
J Am Chem Soc; 2012 May; 134(18):7648-51. PubMed ID: 22524291
[TBL] [Abstract][Full Text] [Related]
6. Structural characterization of lacticin 3147, a two-peptide lantibiotic with synergistic activity.
Martin NI; Sprules T; Carpenter MR; Cotter PD; Hill C; Ross RP; Vederas JC
Biochemistry; 2004 Mar; 43(11):3049-56. PubMed ID: 15023056
[TBL] [Abstract][Full Text] [Related]
7. Isolation, structure elucidation, and synergistic antibacterial activity of a novel two-component lantibiotic lichenicidin from Bacillus licheniformis VK21.
Shenkarev ZO; Finkina EI; Nurmukhamedova EK; Balandin SV; Mineev KS; Nadezhdin KD; Yakimenko ZA; Tagaev AA; Temirov YV; Arseniev AS; Ovchinnikova TV
Biochemistry; 2010 Aug; 49(30):6462-72. PubMed ID: 20578714
[TBL] [Abstract][Full Text] [Related]
8. Lantibiotics: insight and foresight for new paradigm.
Nagao J; Asaduzzaman SM; Aso Y; Okuda K; Nakayama J; Sonomoto K
J Biosci Bioeng; 2006 Sep; 102(3):139-49. PubMed ID: 17046525
[TBL] [Abstract][Full Text] [Related]
9. Structure and dynamics of the lantibiotic mutacin 1140.
Smith L; Zachariah C; Thirumoorthy R; Rocca J; Novák J; Hillman JD; Edison AS
Biochemistry; 2003 Sep; 42(35):10372-84. PubMed ID: 12950164
[TBL] [Abstract][Full Text] [Related]
10. Purification and characterization of a novel delta-lysin variant that inhibits Staphylococcus aureus and has limited hemolytic activity.
Al-Mahrous M; Sandiford SK; Tagg JR; Upton M
Peptides; 2010 Sep; 31(9):1661-8. PubMed ID: 20561552
[TBL] [Abstract][Full Text] [Related]
11. Biosynthesis of the antimicrobial peptide epilancin 15X and its N-terminal lactate.
Velásquez JE; Zhang X; van der Donk WA
Chem Biol; 2011 Jul; 18(7):857-67. PubMed ID: 21802007
[TBL] [Abstract][Full Text] [Related]
12. The biosynthesis of the lantibiotics epidermin, gallidermin, Pep5 and epilancin K7.
Bierbaum G; Götz F; Peschel A; Kupke T; van de Kamp M; Sahl HG
Antonie Van Leeuwenhoek; 1996 Feb; 69(2):119-127. PubMed ID: 8775972
[TBL] [Abstract][Full Text] [Related]
13. Isolation of a new epidermin variant from two strains of Staphylococcus epidermidis--frequency of lantibiotic production in coagulase-negative staphylococci.
Israil AM; Jack RW; Jung G; Sahl HG
Zentralbl Bakteriol; 1996 Jul; 284(2-3):285-96. PubMed ID: 8837389
[TBL] [Abstract][Full Text] [Related]
14. Posttranslationally modified bacteriocins--the lantibiotics.
Guder A; Wiedemann I; Sahl HG
Biopolymers; 2000; 55(1):62-73. PubMed ID: 10931442
[TBL] [Abstract][Full Text] [Related]
15. Sequence analysis of lantibiotics: chemical derivatization procedures allow a fast access to complete Edman degradation.
Meyer HE; Heber M; Eisermann B; Korte H; Metzger JW; Jung G
Anal Biochem; 1994 Dec; 223(2):185-90. PubMed ID: 7887461
[TBL] [Abstract][Full Text] [Related]
16. Isolation and structural characterization of capistruin, a lasso peptide predicted from the genome sequence of Burkholderia thailandensis E264.
Knappe TA; Linne U; Zirah S; Rebuffat S; Xie X; Marahiel MA
J Am Chem Soc; 2008 Aug; 130(34):11446-54. PubMed ID: 18671394
[TBL] [Abstract][Full Text] [Related]
17. A novel lantibiotic acting on bacterial cell wall synthesis produced by the uncommon actinomycete Planomonospora sp.
Castiglione F; Cavaletti L; Losi D; Lazzarini A; Carrano L; Feroggio M; Ciciliato I; Corti E; Candiani G; Marinelli F; Selva E
Biochemistry; 2007 May; 46(20):5884-95. PubMed ID: 17469849
[TBL] [Abstract][Full Text] [Related]
18. Lantibiotic engineering: molecular characterization and exploitation of lantibiotic-synthesizing enzymes for peptide engineering.
Nagao J; Aso Y; Shioya K; Nakayama J; Sonomoto K
J Mol Microbiol Biotechnol; 2007; 13(4):235-42. PubMed ID: 17827974
[TBL] [Abstract][Full Text] [Related]
19. Structural characterization of thioether-bridged bacteriocins.
Lohans CT; Vederas JC
J Antibiot (Tokyo); 2014 Jan; 67(1):23-30. PubMed ID: 24022605
[TBL] [Abstract][Full Text] [Related]
20. Characterization of new class III lantibiotics--erythreapeptin, avermipeptin and griseopeptin from Saccharopolyspora erythraea, Streptomyces avermitilis and Streptomyces griseus demonstrates stepwise N-terminal leader processing.
Völler GH; Krawczyk JM; Pesic A; Krawczyk B; Nachtigall J; Süssmuth RD
Chembiochem; 2012 May; 13(8):1174-83. PubMed ID: 22556031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
